Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluating the Pharmacokinetics and Drug Interaction Potential of the Botanical Dietary Supplement Cinnamon
Sponsor: Washington State University
Summary
The purpose of this study is to evaluate a well-characterized, commercially available cinnamon dietary supplement as a precipitant of pharmacokinetic interactions with cytochrome P450 (CYP) 2A6 drug substrates in healthy volunteers. Nicotine gum will be used as the CYP2A6 probe drug (i.e., positive control) and letrozole as a high-impact object drug. Results will be used to inform future research on the potential use of cinnamon as a smoking cessation agent, as well as the clinical impact on pharmacotherapeutic regimens involving letrozole in cancer patients.
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2021-12-14
Completion Date
2024-08-31
Last Updated
2026-08-24
Healthy Volunteers
Yes
Conditions
Interventions
Cinnamon (2 g)
oral capsules, 2 g
Nicotine gum (2.5 mg)
gum, 2.5 mg
Letrozole (2.5 mg)
tablet, 2.5 mg
Locations (1)
Washington State University College of Pharmacy and Pharmaceutical Sciences
Spokane, Washington, United States